Increasing glycomics research, rising investment in drug discovery and development, and growing opportunities in biopharmaceutical sector are key factors driving market growth.
Increasing glycomics research, rising investment in drug discovery and development, and growing opportunities in biopharmaceutical sector are key factors driving market growth
The global glycomics/glycobiology market size is expected to reach USD 2.88 Billion by 2028 at a CAGR of 14.1%, according to the latest report by Reports and Data. Advancements in glycomics research, growing R&D investment by pharmaceutical and biotechnology companies, and rapid development of novel drugs and therapeutics are key factors expected to drive market revenue growth over the forecast period. Rising funding, grants, and financial support by governments to expand scope of glycomics research in academic and research institutes is also a key factor expected to drive revenue growth of the market over the forecast period. Growing need for novel and efficient therapeutics and drugs to cater to unmet medical demand across the globe has been boosting demand for advanced glycomics and glycobiology tools, and this is expected to further fuel revenue growth of the market over the forecast period.
Glycomics is a subset of glycobiology and is a comprehensive and systematic study of glycomes and glycan structures in any cells or organisms. Glycomics has vast array of applications in diagnostics, cancer research and therapeutics, drug discovery and development, and immunology, among others. Glycans play a pivotal role in innate immunity, cellular signaling pathways, in stability and folding of proteins, and modulation of cell functions. Extensive research in bacterial glycomics has led to the development novel drugs and glycoconjugate vaccines and this is expected to continue going ahead and drive market revenue growth over the forecast period.
Increasing application of glycobiology in cancer research owing to significant role of surface glycans in metastatic and neoplastic properties of tumor cells is expected to contribute to market growth over the forecast period. Growing use of glycans in drug discovery and development and in production of therapeutic monoclonal antibodies are key factors expected to drive market growth over the forecast period. However, high costs of instrument and complexity of glycomes are expected to restrain research activities and hamper market growth to a certain extent over the forecast period.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/3986
Some Key Highlights from the Report:
- Enzymes segment is expected to account for a significant revenue share over the forecast period owing to rising application of enzymes in cancer research and diagnostics. Glycosidases among other enzymes is expected to contribute significantly to revenue growth of this segment owing to its increasing use in oncology research and therapeutic approaches for diseases caused by deficiencies.
- Drug discovery and development segment is expected to register rapid revenue CAGR over the forecast period owing to rising R&D activities in biopharmaceutical sector, growing demand for glycomics products in drug research, and increasing demand for precision medicine to treat chronic diseases.
- Academic and research institutes segment is expected to register robust revenue growth over the forecast period attributable to increasing glycomics research in academic institutes, growing application of glycomics in biomedical research, and rising number of collaborations between research institutes and pharmaceutical and biotechnology companies.
- North America market revenue is expected to expand significantly over the forecast period owing to increasing research activities in glycobiology, fast-paced drug research and development processes, and robust presence of key companies in the region.
- Key companies in the global market include Thermo Fisher Scientific, Inc. Merck KGaA, Agilent Technologies Bruker Corporation, New England Biolabs, Danaher, Shimadzu Corporation, Takara Bio, Inc., Asparia Glycomics S.L, and ProZyme.
- In December 2020, National Health & Medical Research Council (NHMRC) offered Griffith University’s Institute for Glycomics a grant of USD 2.66 Million under Ideas Grant Funding to support four crucial glycomics research studies. The grant will be used for developing vaccines against bacteria, viruses, and bacterial toxins.
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/glycomics-glycobiology-market
For the purpose of this report, Reports and Data has segmented the global glycomics/glycobiology market based on, product, application, end-use, and region:
Product Outlook (Revenue, USD Billion; 2018-2028)
- Enzymes
- Glycosidases & Neuramidases
- Glycosyltransferases & Sialytransferases
- Others
- Instruments
- Mass Spectrometry Instruments
- Chromatography Instruments
- Arrays
- Others
- Kits
- Glycan Releasing Kits
- Glycan Labelling Kits
- Glycan Purification Kits
- Others
- Reagents
Application Outlook (Revenue, USD Billion; 2018-2028)
- Drug Discovery & Development
- Diagnostics
- Others
End-use Outlook (Revenue, USD Billion; 2018-2028)
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- CROs
- Others
Buy Premium Research Report @ https://www.reportsanddata.com/report-pricing/3986
Regional Outlook (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/3986
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Otitis Drug Market , By Disease Type (Acute Otitis Media, Otitis Media with Effusion, Chronic Otitis Media with Effusion), By Drug Types (Antibiotics, Non-steroidal Anti-inflammatory, Analgesic, Anaesthetic, Others), By End-User Type (Hospitals, Homecare, Specialty Clinics, Others), By Treatment Type (Medication and Surgery), and By Region Forecast to 2028.
Glaucoma Treatment Market By Disease Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others), By Drug Class, By Distribution Channel, By Administration, and By Region Forecast to 2028
Protein Expression Market Size, Share & Analysis, By Expression System (Prokaryotic, Mammalian, Yeast, Insect, Cell-Free, Others), By Products (Reagents, Competent Cells, Instruments, Services), By Application (Therapeutic, Industrial, Research), By End-Use Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Cros, Others), And By Region, Forecast To 2028
Pedicle Screw Market Size, Share, And Industry Analysis By Product Type (Polyaxial, Monoaxial, Others), By Surgery Type (Open, Minimally and Invasive), By Indication (Spinal, Trauma, and Others), By Application (Thoracolumbar Fusion, Spinal Cervical Fusion, and Others), By End-Use, And By Region Forecast To 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-glycomics-glycobiology-market